Dengue has been a serious challenge to public health as it affects lakhs of people annually in India. Sanofi Pasteur, the French drugmaker’s vaccine unit, has come up with a vaccin to fight against dengue. Company says that the phase III efficacy clinical study programme for the dengue vaccine candidate was conducted in over 31,000 participants across 10 endemic countries in Asia and Latin America. Results of the last stage of the clinical study shows that the vaccine gives a 95.5% protection against severe dengue and an 80.3% reduction in the risk of hospitalisation. Committed to dengue vaccine research for more than 20 years, Sanofi Pasteur aims to make the tropical ailment the next vaccine-preventable disease.They will file for registration of its vaccine candidate and subject to regulatory approval the world’s first dengue vaccine could be available by the second half of 2015.
Check Also
Study revealed how bacteria drills into our cells and kill them
A team of scientists has revealed how certain harmful bacteria drill into our cells to ...
Bacteria turns into a storage device
A new DNA-based recorder allows bioengineers to create cell cultures that detect information in their ...
DNA-based computer circuit comes to reality with molecular electronics
Scientists have achieved the most significant breakthrough towards developing DNA-based electrical circuits. Molecular electronics, which uses ...
Stem cells to fight brain cancer
Scientists from Harvard Medical School have discovered a way of turning stem cells into killing ...
Why some people are better navigators
The part of the brain that tells us the direction to travel when we navigate ...